Open AccessDexmedetomidine Related Polyuria and Hypernatremia in Intensive Care Unit.
Author(s) -
Mubashar Dilawar,
Muhammad Mohsin Riaz,
Omer Sabir,
Muhammad Bilal Basit
Publication year - 2021
Publication title -
pakistan journal of kidney diseases
Language(s) - English
Resource type - Journals
eISSN - 2708-3020
pISSN - 2617-0329
DOI - 10.53778/pjkd502142
Subject(s) - dexmedetomidine , polyuria , medicine , diabetes insipidus , hypernatremia , vasopressin , anesthesia , sedation , polydipsia , intensive care unit , anesthetic , intensive care medicine , diabetes mellitus , endocrinology , chemistry , organic chemistry , sodium
Dexmedetomidine is commonly used sedative nowadays. It’s being used as an anesthetic for surgical procedures and frequently being used in ICU Settings for sedation, and analgesia. Dexmedetomidine is a highly selective, alpha-2 agonist that also blocks arginine-vasopressin release. Dexmedetomidine is suspected to cause diabetes insipidus leading to polyuria and hypernatremia. We report a case of Diabetes Insipidus associated with use of dexmedetomidine.